Twitxy Saved

Shu Wang, MD

@ShuWangMD

Urology resident @WCMUrology | Former research fellow @MarylandUrology | Alumni @PKU1898 | Views my own
New York, NY Joined April 2017
925 Following 1K Followers 730 Posts

Latest posts 5

Shu Wang, MD @ShuWangMD
Proud to have been part of this team effort. Great early signal for #RTIRE in intermediate-risk prostate cancer — excited to see where the phase II data and #IRRADIANT trial take us next.
Himanshu Nagar Verified account @HimanshuNagarMD Jul 28
Phase 1 #RTIRE: focal IRE + reduced-dose RT (32.5 Gy/5 fx) for intermediate risk prostate cancer:
✅ 10/10 negative biopsies at 12 mo
✅ No grade 3–5 AEs

Promising, NOT definitive.
pubs.rsna.org/doi/epdf/10.11…

Next: phase 2 data final report in 42 patients → ongoing randomized #IRRADIANT trial (cancer.gov/research/parti…).
View quoted post on X
1 replies 0 reposts 9 likes 2.2K views View on X